Respiratory Syncytial Virus Prefusion F (RSVpreF) vaccination is effective against RSV-related lower respiratory tract disease (LRTD) among adults aged 60 years or older, according to a study published online Dec. 13 in JAMA ...
Dec 18, 2024
0
16
In most people, the lung-infecting pathogens known as respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) trigger mild cold-like symptoms. But in infants and seniors, these viruses can cause severe pneumonia ...
Nov 19, 2024
0
26
Vanderbilt University Medical Center and Stanford University researchers discovered a potent, cross-neutralizing human monoclonal antibody against the respiratory syncytial virus (RSV) and human metapneumovirus (hMPV).
Aug 7, 2023
0
82
A little-known respiratory virus is grabbing the limelight from COVID-19 and RSV after cases surged earlier this year, spurring companies to prepare their vaccines for a waiting market.
Jun 2, 2023
0
217
If you came down with a respiratory infection in the spring and it wasn't influenza (flu), COVID-19 or RSV, it may have been a virus you've never heard of.
Jun 1, 2023
0
70
In the year 2000, Dutch scientists went on a mission of exploration—not to discover lands or riches, but to identify unknown causes of acute respiratory infections.
Apr 12, 2023
0
34
